Uzm. Dr. Serkan Gülcü

Doctor and researcher Ankara Etlik Şehir Hastanesi Ankara
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • Department name at the sourceOnkolojisaglik.gov.trFrom source
  • InstitutionAnkara Etlik Şehir Hastanesisaglik.gov.trFrom source
  • Publications12 publicationsOpenAlex, ORCIDFrom source
  • ORCID0000-0003-0708-4940ORCIDFrom source
  • Last synchronised5 November 2026 07:23https://etliksehir.saglik.gov.tr/TR-864408/klinik-doktorlarimiz.html#serkan-gulcusaglik.gov.tr

Scientific work

Publications

12 publications

  1. Real-World Outcomes of CDK4/6 Inhibitors in Germline BRCA1/2-Mutated Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study

    Current Oncology, 2026

    DOI 10.3390/curroncol33060365 PMID 42346265 Open-access full textSource: OpenAlex

  2. Prognostic Impact of Clinicopathological and Inflammatory Markers in Surgically Treated Pulmonary Invasive Mucinous Adenocarcinoma

    Seminars in Thoracic and Cardiovascular Surgery, 2026

    DOI 10.1053/j.semtcvs.2025.08.007 PMID 40975455 Source: ORCID

  3. Baseline vitamin D levels and progression-free survival in patients with HR+/HER2-metastatic breast cancer treated with ribociclib: a retrospective single-center analysis

    Discover Oncology, 2026

    DOI 10.1007/s12672-026-05502-2 PMID 42340556 Open-access full textSource: ORCID

  4. Investigation of systemic treatment responses and prognostic factors in metastatic gastroenteropancreatic neuroendocrine carcinomas (GEP-NECs)

    Journal of Health Sciences and Medicine, 2025

    DOI 10.32322/jhsm.1744286 Open-access full textSource: ORCID

  5. Prognostic Value of Inflammatory Markers, CA 19-9, MELD Score, and ECOG in Stage 4 Gastric Cancer with Liver Metastases

    Acta haematologica oncologica Turcica., 2025

    DOI 10.4274/ahot.galenos.2025.2025-5-4 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  6. Vitamin D Deficiency Predicts Poor Survival in CDK4/6 Inhibitor Treated HR+/HER2− Metastatic Breast Cancer

    SSRN Electronic Journal, 2025

    DOI 10.2139/ssrn.5600973 Open-access full textSource: OpenAlex

  7. Kanser Hastalarının Başvurduğu Geleneksel ve Tamamlayıcı Tedaviler - Tıbbi Onkolog Gözü ile Bakış ve Onkolojik İlaçlarla Etkileşim

    Akademisyen Kitabevi eBooks, 2024

    DOI 10.37609/akya.2380 Open-access full textSource: OpenAlex

  8. Garcinol (Garcinia Cambogia)

    Akademisyen Kitabevi eBooks, 2024

    DOI 10.37609/akya.2380.c13895 Source: ORCID

  9. Clinicopathological and Demographics Analysis of Testicular Tumors: A Single-center Experience

    Acta haematologica oncologica Turcica., 2024

    DOI 10.4274/ahot.galenos.2024.95666 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  10. Anti-Neoplastik İlaçlar

    Akademisyen Kitabevi eBooks, 2023

    DOI 10.37609/akya.2429 Open-access full textSource: ORCID

View all 12 publications